A network meta-analysis of direct oral anticoagulants for portal vein thrombosis in cirrhosis.

Cheng-Han NgDarren Jun Hao TanKameswara Rishi Yeshayahu NistalaNicholas SynJieling XiaoEunice Xiang Xuan TanFelicia Zuying WooNicholas W S ChewDaniel Q HuangYock Young DanArun J SanyalMark Dhinesh Muthiah

Published in: Hepatology international (2021)

The network analysis supports the use of DOACs in cirrhotic patients, with significant rates of complete recanalization compared to other treatments without increasing bleeding risk. DOACs can potentially be considered for nontumorous PVT in cirrhosis.

Keyphrases

direct oral anticoagulants
network analysis
atrial fibrillation
venous thromboembolism
pulmonary embolism
middle cerebral artery
endovascular treatment
breast cancer risk